Shares of CVS Health Corp (CVS) were volatile in trading on Monday after is was reported that Amazon’s pharmacy licenses were not intended to be used to move the company into the distribution of prescription drugs, but rather into the sale of other health related products, such as medical devices. Previously, the markets were under the impression that Amazon intended to become a direct competitor to CVS in the drug distribution business. However, many still expect that Amazon will eventually move into this space once it has established a foothold in the overall healthcare industry. CVS shares spiked as high as over 73.00 per share before settling down at 71.48, up +0.17% for the session. Keep an eye on the stock for further developments.
Shares of Textron Aerospace and Defense Company (TXT) were moderately volatile in trading on Friday due to a rumor that the company is a potential takeover target. While shares initially reacted to this rumor by trading quickly higher, they ultimately returned back to the prevailing price range and settled at 54.27, down only -0.24%. Keep an eye on the stock are more rumors are likely.
Shares of Hertz Global Holdings (HTZ) rose sharply in after hours trading on Thursday after the company reported its Q3 earnings results. The company beat EPS $1.32 estimate with $1.42 adjusted EPS. Also, sales came in at $2.6B vs. $2.57B estimate. HTZ traded as high as +13.8% in post market trading. Keep an eye on the stock for further potential volatility.
Shares of Monsanto (MON) sunk in trading on Wednesday after an Arkansas regulatory body decided to bar the company’s latest weedkiller product for a second consecutive summer. The product is crucial for MON’s seed sales and has been an ongoing dispute for over a year now. In addition to these troubles, European regulators decided to push back review of the proposed Bayer-Monsanto merger to March 2018, setting back potential closing of the deal. MON shares closed down -1.81% to settle at 117.38 for the session. Keep an eye on the stock for further developments.
Shares of Wayfair Company (W) sank in trading on Tuesday after it was reported that Amazon is offering furniture brands. This marks yet another company impacted by the expansion of Amazon its own private label brands and services. W shares closed down -5.92% to finish at 60.26. Keep an eye on the stock for further developments.
Shares of Alkermes Company (ALKS) fell in trading on Monday after news that Senator Kamala Harris launched an investigation into the company’s treatment of opioid addiction. The investigation is seeking evidence to determine if ALKS artificially boosted its sales of Vivitrol, which is a drug used in treatment of opioid addiction. ALKS shares closed down -4.37% to settle at 48.76. Keep an eye on the stock as this situation is still developing.
Shares of Aetna Insurance Company (AET) rose sharply in trading on Friday after it was reported that it might finalize a deal with CVS by December of this year. CVS intends to buy AET, and the deal is currently estimated to be worth more than $70B, which potentially values AET at more than $200 per share. AET closed up +2.71% to settle at 176.99. Keep an eye on AET as this story is developing.
Shares of Time Warner (TWX) took a hit in trading on Thursday due to news that the Department of Justice is considering filing an antitrust lawsuit against the company over its planned buyout by AT&T. The $85B deal was agreed upon last year between the two companies, but there was already considerable concern that the DOJ would block the deal. TWX shares closed down -3.75% to settle at 94.70. Keep an eye on the stock for further developments.
Shares of Check Point Software (CHKP) sunk after earnings were reported after market on October 31st. The stock has since settled down -12.49% from Wednesday’s close, finishing at 103.01. While the company did report an EPS beat above estimates, it’s Q4 projections were soft, leading traders to dump the stock. Keep an eye on CHKP going forward as adjustments to this view are likely.
Shares of Mylan N.V. (MYL) were slammed in trading on Tuesday due to a lawsuit alleging the company of conspiring to fix generic drug prices. The company’s president, Rajiv Malik, was named in the lawsuit. This marks a strong development in the ongoing probe into prescription drug pricing that should yield more volatility to the sector as time proceeds. MYL shares settled down -6.62% to close at 35.11 for the session. Keep an eye on the stock as this story is still developing.